Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05336240 · ClinicalTrials.gov registry record · NA
PCOM2 - The Physician Communication Intervention, Version 2.0
A NA study of HPV Infection and Preventive Health Services, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 2
- Study locations
NCT05336240 is a NA study of HPV Infection and Preventive Health Services that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 120 participants, below the 227-participant average among 13 other HPV Infection trials with a reported enrollment target (47% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05336240, a NA study of HPV Infection and Preventive Health Services, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 2
- Study locations
Study Summary
Poor quality of primary care providers' vaccine recommendations lead to low adolescent human papillomavirus vaccination rates and hundreds of thousands of adolescents unnecessarily at risk for HPV-associated cancers and diseases. Though a previous provider communication intervention, called PCOM, was found to be effective for increasing adolescent HPV vaccination in primary care, its dissemination is limited by the need for significant research team involvement to teach providers how to use the intervention's components. To address this, investigators propose to develop and test a virtual version of PCOM, use mixed methods to assess contextual factors affecting its use compared to the original PCOM intervention, and develop an optimized version of PCOM for broad dissemination to increase adolescent HPV vaccination nationally.
Conditions Studied
Interventions
- BEHAVIORAL Physician Communication 2 Virtual (PCOM2-virtual)
- BEHAVIORAL Physician Communication Standard (PCOM-standard)
Study Locations (2)
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Kansas
- University of Kansas Medical Center - Wichita
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-11-15 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05336240
The ClinicalTrials.gov registry entry for NCT05336240 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 227-participant average among 13 other HPV Infection trials with a reported enrollment target (47% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HPV Infection appearing as the primary indexed condition, and to 2 interventions - of which Physician Communication 2 Virtual (PCOM2-virtual) is the first listed.
NCT05336240 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Colorado, Kansas.
Frequently Asked Questions
What is clinical trial NCT05336240 about?
NCT05336240 is a clinical study titled "PCOM2 - The Physician Communication Intervention, Version 2.0". Poor quality of primary care providers' vaccine recommendations lead to low adolescent human papillomavirus vaccination rates and hundreds of thousands of adolescents unnecessarily at risk for HPV-associated cancers and diseases. Though a previous provider communication intervention, called PCOM, wa...
What is the current status of trial NCT05336240?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-11-15. Estimated completion is 2026-12-31.
What conditions does trial NCT05336240 study?
This clinical trial studies the following conditions: HPV Infection, Preventive Health Services.
What interventions are being tested in trial NCT05336240?
The interventions under investigation include: Physician Communication 2 Virtual (PCOM2-virtual) (BEHAVIORAL), Physician Communication Standard (PCOM-standard) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05336240?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05336240 being conducted?
This trial has 2 study locations across Colorado, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HPV Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
RECRUITING · NA
-
Game-Based Intervention to Promote HPV Vaccination
ACTIVE NOT RECRUITING · NA
-
SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening
ACTIVE NOT RECRUITING · NA
-
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
RECRUITING · Phase 4
-
Feasibility of HPV Testing With Mail-delivered Sample Collection Kits
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.